GeneMachines Hyb4

The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...

... is a wearable CPAP (Continuous Positive Airway ... apnea. The lightweight BreatheX CPAP device (patent ... its built-in, rechargeable battery, and is mobile, ... longer need to be "plugged in to ...

Paraffin Block Storage System...

Shandon Paraffin Block Cabinet...

Medicine Products:

Tag-It Cystic Fibrosis PCR Mix BreatheX™ CPAP device Paraffin Block Storage System Shandon Paraffin Block Cabinet

(Date:12/15/2009)... Accelify is proud to announce the addition of David ... serve as Director of Development in the State of ... Advisors. ,, David Tokofsky was elected to ... in June 1995. As the Board Member for District ... from Northeast Los Angeles through East Los Angeles to ...

(Date:12/15/2009)... R.I., Dec. 15 Mergers and acquisitions ... expand their reach globally or complete a product ... the integration of safety programs. ,, A new ... Best Practices in a Hearing Conservation Program: US ... Airways and America West led the newly formed ...

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... -- Research shows a direct correlation between effective ... building a culture of health improvement can result ... a new white paper from The Vitality Group, ... represents an ideal setting for the delivery of ... a corporate culture of health is a critical ...

(Date:12/15/2009)... -- The following is being released by the American ... Vera Rulon, MS, RHIT, CCS, FAHIMA ,, ... you joining us... ,, On behalf of the A-H-I-M-A ... our next chief executive officer, Doctor Alan Dowling... ,, ... search for someone who we knew could ...

[0] Accelify Announces the Addition of David Tokofsky to its National Board of Advisors [0] New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways [0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Optimizing Corporate Culture is Critical to the Success of Wellness Programs [0] Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST

... (Nasdaq: KERX ) today announced that on ... Stock Market ("Nasdaq") stating that the Company is no ... the Company to have a minimum of $2,500,000 in ... or $500,000 of net income from continuing operations for ...

... Pa., Nov. 21 Escalon Medical Corp. (Nasdaq: ... completed a $1,100,000 private placement of common stock and common ... Company sold 1,000,000 shares of common stock at $1.10 per ... additional 150,000 shares of common stock at an exercise price ...

... pioneer Compressus,Inc. today introduced the next generation ... software solutions with the release of the,MEDxConnect(TM) ... features a full,integration with GE Centricity PACS ... solutions package that increase the,efficiency and automation ...

... VICL ) today announced a strategic restructuring ... the company,s total workforce,and accelerated closure of a research ... employees and expects to reduce future,net losses and cash ... The restructuring is designed to ...

... wanted to get cosmetic surgery but either couldn,t afford it or ... the fear out of cosmetic surgery with a nonsurgical facelift that,s ... What more could you ask for? , ... Coral ...

... Web-based ,eValuator, tool developed to help businesses assess the health and value ... ... Bartlett Communications, an interactive design agency, has launched a new website tool ... with a resource to gauge the health and value of their website, ...

Other Medicine News:Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 2 Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 3 Health News:Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing 2 Health News:Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing 3 Health News:Compressus' Next Generation MEDxConnect(TM) Interoperability Solutions Feature GE Centricity and Philips iSite Integrations 2 Health News:Compressus' Next Generation MEDxConnect(TM) Interoperability Solutions Feature GE Centricity and Philips iSite Integrations 3 Health News:Compressus' Next Generation MEDxConnect(TM) Interoperability Solutions Feature GE Centricity and Philips iSite Integrations 4 Health News:Vical Announces Strategic Restructuring and Staff Reduction 2 Health News:Vical Announces Strategic Restructuring and Staff Reduction 3 Health News:Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift 2 Health News:Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift 3 Health News:Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift 4 Health News:Bartlett Communications Launches Free Website Evaluation Tool for Small to Mid-Sized Businesses 2

Keryx Biopharmaceuticals Receives Nasdaq Notification Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing Compressus' Next Generation MEDxConnect(TM) Interoperability Solutions Feature GE Centricity and Philips iSite Integrations Vical Announces Strategic Restructuring and Staff Reduction Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift Bartlett Communications Launches Free Website Evaluation Tool for Small to Mid-Sized Businesses

(Date:12/15/2009)... Iowa, Dec. 15 Vivakor, Inc. ... Vivakor,s divisions have reported strong performance in ... research and development with divisional spokes developing ... R&D Product Pipeline strategy is anchored to ... From idea inception, Vivakor,s R&D efforts target ...

(Date:12/15/2009)... Calif., Dec. 15 Genomic Health, Inc. (Nasdaq: ... studies on its Onco type DX® breast cancer ... to predict the likelihood of chemotherapy benefit and recurrence ... were presented at the 32nd Annual CTRC-AACR San Antonio ... in San Antonio, TX. ,, "The breadth of data ...

(Date:12/15/2009)... Mass., Dec. 15 Arlington Medical Resources ... Staphylococcus aureus (MRSA) is the most concerning ... regard to their treatment of skin and skin ... among the top factors that influences European physician ... infections. Other key factors that drive prescribing include ...

Breaking Medicine Technology:Vivakor Divisions Continue to Demonstrate Independent Growth 2 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3 American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection USP 15 mg mL 3B 1mL Single Dose Vials 5964 1 American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection USP 15 mg mL 3B 1mL Single Dose Vials 5964 2 Study 3A Lap band surgery effective for morbidly obese children 60640 1 Renowned cardiovascular researcher to receive Taylor Prize 60638 1

[0] Vivakor Divisions Continue to Demonstrate Independent Growth [0] Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations [0] A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections

Products	GeneMachines Hyb4
Company	Genomic Solutions
Item	GeneMachines Hyb4
Features	Inquire
Description	The GeneMachines Hyb4 is built upon the success of the first automated hybridization for microarrays. The unit automates all thermal and wash cycles for the hybridization of microarrays spotted on standard glass slides. A 4-position GeneMachines Hyb4 allows 4 slides to be hybridized, while the individual ports allow for independent probe introduction for each microarray. Minimizes handling of microarrays, substantially reducing human error. That means better control over the experimental variables, resulting in increased reproducibility of the hybridization. Increase your research flexibility by defining, editing and storing individual methods using the Methods Editor software on your PC.
Info	Genomic Solutions Customer Service: (734) 975-4800 Web site: http://www.genomicsolutions.com/